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Ultraviolet radiation is the most common environ-
mental carcinogen humans are exposed to. It is now
known that in order for skin cancers to develop,
both genetic damage and immunosuppression is
required. Ultraviolet-induced immunosuppression is
therefore a key contributor to the development of
skin cancer. Little is known about the relative contri-
butions of the different ultraviolet spectra (A and B),
however. Therefore detailed ultraviolet dose±
response curves for systemic suppression of contact
hypersensitivity in two mouse strains were deter-
mined to examine the relative contributions of each
of these spectral components of sunlight to primary
and secondary immunity. Whereas ultraviolet B
caused a linear dose-related immunosuppression in
both C57BL/6 and Balb/c mice, only C57BL/6 mice
were immunosuppressed by medium doses of ultra-
violet A. At higher ultraviolet A doses, C57BL/6
mice were protected from immunosuppression, sug-
gesting a genetic predisposition to ultraviolet-A-
induced immunomodulation. Surprisingly, we found
that, in contrast to primary immunosuppression, low
dose ultraviolet A enhanced the secondary immune
response, whereas ultraviolet B caused antigen-spe-
ci®c tolerance. When ultraviolet A and ultraviolet B
were combined to mimic sunlight (solar-simulated
ultraviolet), immunosuppression and tolerance were
only observed over a narrow dose range as the mem-
ory-enhancing effect of low dose ultraviolet A and
the immunoprotective effect of higher dose ultravio-
let A prevented the suppressive effects of ultraviolet
B. These studies suggest that complex relationships
between ultraviolet dose, immunomodulation, spec-
tra, and genetic background are likely to be import-
ant for skin cancer induction. We also describe for
the ®rst time that low doses of ultraviolet A are able
to enhance secondary immunity, which has import-
ant implications for vaccination strategies. Key words:
immunomodulation/immunosuppression/skin cancer/sun-
light/ultraviolet. J Invest Dermatol 119:858±864, 2002
T
he ultraviolet (UV) wavelengths in sunlight are the
prime etiologic agents responsible for causing both
melanoma (Armstrong and Kricker, 1993; Klein-
Szanto et al, 1994) and epithelial skin cancer (Kricker
et al, 1995; Li et al, 1995). Sunlight is made up of both
UVB (290±320 nm) and UVA (320±400 nm) with the UVB
component being at a much lower intensity than UVA. UV
radiation-induced suppression of the immune system is an
important step in carcinogenesis as it prevents the natural defence
against skin cancer. The Food and Drug Administration (FDA,
Federal Register, Vol. 64, no. 98, Friday May 21, 1999, pages
27666±27693) have recently acknowledged that both UV-induced
genetic mutation and immunosuppression are required to develop
skin cancer (Donawho and Kripke, 1991). Therefore, to under-
stand and protect against skin cancer, it is necessary to determine
the doses of UV that in¯uence the immune system as well as the
role of different wavebands in sunlight. Controversy surrounds the
relative roles of UVA compared to UVB, however, and
comparative dose±responses have not been established. UVA can
induce immunosuppression in both mice and humans (Halliday et
al, 1998; Damian et al, 1999; Nghiem et al, 2001), and in animal
models UVA has been shown to contribute to the development of
both squamous cell carcinoma (Kelfkens et al, 1992) and melanoma
(Ley, 1997). Others have also found that UVA does not alter
immunity, however (Skov et al, 1997; Dittmar et al, 1999).
Conversely, there is evidence that high doses of UVA can protect
mice and humans from UVB-induced immunosuppression (Reeve
et al, 1998; Skov et al, 2000; Garssen et al, 2001). The experiments
described here aimed to clarify the roles of UVA and UVB in UV-
induced systemic suppression and tolerance to contact sensitization
by constructing dose±response curves for UVA, UVB, and solar-
simulated UV radiation (ssUVR). The results show complex
interactions dependent on dose, spectra, and genetic background.
MATERIALS AND METHODS
Mice Female C57BL/6 and Balb/c mice aged 7±8 wk at the start of
irradiations were used in these experiments (Animal Resource Center,
Perth, WA, Australia), which were conducted with the approval of the
Sydney University animal ethics committee.
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UV source UVA, UVB, and ssUVR spectra were produced with a
1000 W xenon arc solar simulator (Oriel, Stratford, CT). For ssUVR,
two dichroic mirrors that each allow wavelengths between 200 nm and
400 nm to pass through were used in conjunction with an atmospheric
attenuation ®lter to produce a spectrum closely resembling sunlight. By
changing this ®lter for one that blocks UVB radiation, a spectrum
containing mostly UVA was produced. Alternatively, by changing the
two dichroic mirrors to ones that re¯ect wavelengths between 260 nm
and 320 nm, a spectrum containing mostly UVB was produced. The
intensity (mW per cm2) of the UV output was measured continuously
using a radiometer (Solar Light Company, PA), and the timing of UV
exposure was adjusted with an automated timing device so that accurate
UV doses (measured in mJ per cm2) could be delivered to individual
mice. Spectral output of the solar simulator (both intensity and
wavelength) was measured using an OL-754 spectroradiometer
(Optronic Laboratories, Orlando, FL), which was calibrated against
standard lamps for spectra and intensity and was used to calibrate the
radiometer against the source. Additionally, the spectral output of the
sun was measured for comparison on October 10, 2001, at midday on a
cloudless day in Sydney, Australia.
UV irradiations The minimum dose to induce edema (the minimum
edematous dose, MEdD) was determined by exposing groups of six to
eight mice to various doses of ssUVR. The pre-UV and 24 h post-UV
skin thickness was measured using a hand-held high frequency ultrasound
(Longport International, Silchester, U.K.) with the minimum dose of
ssUVR required to cause a signi®cant increase in skin thickness being
the MEdD. For ethical reasons, mice were not given any dose greater
than the MEdD. Irradiation times were short (less than 1 min) and a
combination of fans and air-conditioning were used to ensure that the
mouse body temperature did not increase during irradiation.
For each experiment, seven groups of four to seven C57BL/6 or
Balb/c mice each had their back-skin hair removed using animal clippers
(Oster, McMinnville, TN) and a close shave electric razor (Remington,
Austria). Mice were allowed 24 h to recover from any in¯ammatory
effects of the shaving before they were placed in a black perspex animal-
restraining device ®tted with a quartz glass lid for exposure to various
doses and wavelengths of UV radiation. Additionally, the mice ears and
head were shielded from the UV with black perspex. One of six different
UV doses ranging from control unirradiated (0 mJ per cm2) to
1 3 MEdD were delivered to groups of mice each day for three
consecutive days. UV-induced systemic immunosuppression has been
produced by many groups using a variety of irradiation protocols ranging
from single doses to multiple doses over the course of many weeks. The
3 d irradiation regime used in these experiments was based on previous
reports by others using multiple irradiations ranging from 2 to 4 d
(Noonan and De Fabo, 1990; Roberts and Beasley, 1997). The seventh
group was an unirradiated irritant control. Each experiment was repeated
three times with the results normalized and pooled.
Contact hypersensitivity (CHS) response To determine the UV
effects on primary and secondary immunity, CHS was induced (Fig 1).
For systemic immunosuppression (primary immunity) studies, mice that
received UV exposure to the back-skin were sensitized by applying
50 ml of a 2% wt/vol solution of oxazalone (4-ethoxymethylene-2-
pheyl-2-oxazolin-5-one; Sigma Chemical, St. Louis, MO) dissolved in
acetone. This hapten was applied to the shaved abdomen 3 d after the
®nal UV exposure, with positive control unirradiated mice being
sensitized in the same way. To assess the primary CHS, 5 ml of the 2%
oxazalone solution was applied to the right ear of the mice 7 d later.
After a further 24 h, the difference in the thickness between the right
challenged and left unchallenged ears was measured using engineers'
callipers (Mitutoyo, Japan). The increase in ear thickness of negative
control unirradiated, unsensitized but challenged only mice (irritant
control) were subtracted from the test groups.
For evaluation of the effects of UV on the secondary immune
response, these same groups of mice were rested for 8±10 wk (Fig 1).
Memory and/or regulatory T cell activity induced by the primary
sensitization was detected by a second contact sensitization without
further UV irradiation. Thus, the mice were re-sensitized by applying
Figure 1. Experimental design showing time line and order of procedures.
Figure 2. The Oriel 1000 W xenon arc solar simulator emits a
spectrum of UV radiation that closely approximates sunlight. The
spectral output of the Oriel solar simulator was measured using an OL-
754 spectroradiometer at 2 nm intervals (thick solid line). The outputs of
the UVA only spectrum (dashed line) and the UVB only spectrum (dotted
line) were also determined (at 2 nm intervals). These were compared to
the spectral output of midday sun on a typical cloudless spring day on
October 10, 2001, in Sydney, Australia (thin solid line). The log of the
relative spectral irradiance was then plotted against wavelength for the
UV spectrum (280 nm to 400 nm). The UVB, ssUVR, and sunlight
spectra were normalized to a relative spectral irradiance unit of 1
(arbitrary units, AU) at 320 nm, whereas the UVA spectrum was
normalized to 1 at 340 nm. Integration was used to calculate the total
area under each curve as well as the UVB and UVA component areas.
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2% wt/vol oxazolone to the shaved abdomen. CHS was then assessed by
ear challenge to the previously unchallenged (left) ear 7 d later as
described above.
Statistics For assessment of the MEdD, a paired Student's t test was
used and p < 0.05 was considered statistically signi®cant. Differences
between the two strains was compared by a repeated measures ANOVA.
For CHS experiments testing primary and secondary immune responses,
experiments were repeated three times with the same result observed
each time. Results were then normalized against the positive control
group in each experiment and pooled for ®nal analysis. An unpaired
Student's t test was used to test for signi®cance, with p < 0.05 considered
statistically signi®cant.
RESULTS AND DISCUSSION
Many previous studies on the biologic effects of UV have used
banks of ¯uorescent tubes emitting disproportionately large
amounts of UVB (47%) and less UVA (53%) than is found in
sunlight (5% and 95%, respectively). The work described here used
Figure 3. C57BL/6 and Balb/c mice have the same MEdD after
exposure to ssUVR. Groups of six to eight C57BL/6 (j) or Balb/c
(h) mice had their back shaved at least 24 h prior to exposure to various
doses of ssUVR. Immediately before UV irradiation, the initial thickness
of back-skin was measured using a hand-held ultrasound (the pre-UV
measurement). Mice were then immediately exposed to various single
doses of ssUVR. Twenty-four hours after this exposure, the back-skin
was again measured using the hand-held ultrasound (the post-UV
measurement). The difference between the post-UV and pre-UV
measurements was calculated to be the increase in skin thickness and the
minimum dose of ssUVR required to cause a signi®cant increase in the
thickness of the skin was the MEdD. A paired Student's t test was used
to compare the difference between pre- and post-UV thickness in each
individual mouse. Results are presented as mean 6 SEM; *p < 0.05 for
C57BL/6 mice, ²p < 0.05 for Balb/c mice. A repeated measures
ANOVA showed that the magnitude of the increase between the two
mouse strains was signi®cantly different; p < 0.005.
Figure 4. UV Modulation of primary immunity. The primary
immune response was suppressed in both C57BL/6 (j) and Balb/c(h)
mice after exposure to the UVB component of sunlight (a). C57BL/6
mice were signi®cantly immunosuppressed by 1680 mJ per cm2 of UVA,
but recovered at higher UVA doses. Balb/c mice, however, were
unaffected by any UVA dose (b). Exposure of C57BL/6 mice to ssUVR
mirrored the biphasic dose±response seen for UVA only experiments,
but Balb/c mice did not show a recovery from immunosuppression at
higher ssUVR doses (h). In each individual experiment, groups of four
to seven mice had their back-skin shaved 24 h prior to exposure to
various doses of ssUVR, or the relative UVA or UVB components. The
UVB and UVA doses are those components of ssUVR at the appropriate
point. Mice were exposed for three consecutive days and then rested for
three more days before being sensitized to oxazolone and then ear
challenged 7 d later. Twenty-four hours following challenge, CHS was
assessed by measuring ear swelling. Within each dose±response
experiment the change in ear swelling for each mouse that received UV
radiation was normalized to the mean of the control unirradiated group.
Each experiment was repeated three times, with the same result observed
each time, and normalized values were pooled for ®nal analysis and
presentation. The total number of each mouse strain pooled from the
three experiments (the n value) is shown below the axis. Mean 6 SEM
is shown. An unpaired Student's t test was used for statistical analysis; *p
< 0.05 for C57BL/6 mice, ²p < 0.05 for Balb/c mice compared to
unirradiated control mice.
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a xenon arc solar simulator, which provided a better mimic of the
solar spectrum comprising 5.9% UVB and 94.1% UVA (Fig 2).
When using wavebands within the solar spectrum, it was important
for this study that the shape of the waveband remained similar to
that band within the solar spectrum. When the UVB component
was blocked using a UVB/UVC blocking ®lter, the UVA spectrum
closely approximated the UVA component of sunlight with a sharp
cut-off at 320 nm (Fig 2). The percentage of contaminating UVB
present in the UVA spectrum was less than 0.001%, which was
determined by integrating the area under the spectral curve.
Similarly, by changing the dichroic mirrors, a spectrum containing
mostly UVB wavelengths was produced with the UVA wave-
lengths being severely attenuated relative to ssUVR (Fig 2). The
relative spectral irradiance of the UVB spectrum between 290 and
320 nm was a very good approximation of the UVB component of
the solar spectrum (Fig 2). For wavelengths greater than 320 nm
not completely removed, there was a one log reduction in intensity
by 340 nm and a one and a half log reduction in intensity compared
to the solar-simulated spectrum by 370 nm (note that the ®gure is
on a log scale). Therefore, a wavelength distribution similar to that
found in sunlight (ssUVR) as well as the two component spectra
(UVA and UVB) could accurately be delivered to mice. The
delivery of this high intensity output to immobilized single mice
therefore enabled more accurate determination of dose±responses
than has previously been described.
The lowest dose of ssUVR that caused a signi®cant increase in
skin thickness (MEdD) was found to be the same in both mouse
strains (Fig 3). In humans, the minimum erythema dose (MED) is
commonly used to assess the biologic endpoint of erythema or
redness of the skin and is also used to determine the skin type of
individuals. Because mouse skin is pink, however, changes in skin
color cannot be easily detected. Therefore, instead of erythema, the
edemal component of sunburn is commonly used as a way of
measuring sunburn in mice (Cole et al, 1983). We established the
use of a hand-held high frequency ultrasound to accurately
determine the MEdD. This is conventionally measured using
callipers, but we found the ultrasound gave more reproducible
results. The MEdD was 3640 mJ per cm2 of ssUVR, being made up
of 280 mJ per cm2 UVB and 3360 mJ per cm2 UVA (Fig 3).
Although the MEdD was the same for both C57BL/6 and Balb/c
mice, the magnitude of the response between the two strains was
signi®cantly different (p < 0.005; repeated measures ANOVA),
with C57BL/6 mice showing a greater response than Balb/c mice.
All irradiations used for immunosuppression were below the
MEdD so that the biologic changes associated with sunburn did not
confound the immunosuppression studies. This also meant that this
study used ssUVR doses that could be experienced in everyday
situations by humans. As the MEdD was indistinguishable between
the two mouse strains, they can be considered to be of a similar
``skin type''. MEdD does not correlate with sensitivity to
immunomodulation, however (Damian et al, 1997), so this issue
does not complicate interpretation of the immunosuppression
studies.
Results from earlier murine studies demonstrated that single
doses of both UVB and UVA radiation induce antigen-speci®c
immunosuppression as well as tolerance (Halliday et al, 1998),
which is consistent with results obtained in humans (Damian et al,
1999) but inconsistent with studies showing that high dose UVA
protects from the suppressive effects of UVB (Reeve et al, 1998).
To resolve this issue, dose±response studies were performed that
revealed that UVA and UVB, although both immunosuppressive,
display different dose±responses in the different mouse strains.
C57BL/6 mice showed positive control ear swelling responses of
21.4 6 1.6 with irritant controls of 3.6 6 0.6 3 10±2 mm. For
C57BL/6 mice, low doses of the UVB portion of sunlight were
suf®cient to suppress systemic immunity (Fig 4a). This dose (35 mJ
per cm2) was the lowest delivered to mice demonstrating that UVB
is potently immunosuppressive. The amount of UVA contamin-
ating this UVB dose was 66 mJ per cm2 UVA, which was 25-fold
lower than the minimum immunosuppressive UVA dose (Fig 4b).
The level of immunosuppression increased linearly with UVB dose,
which is consistent with other studies exploring the dose±response
effects of UVB on systemic immunosuppression (Noonan and De
Fabo, 1990). Medium dose UVA (1680 mJ per cm2) was also able
to suppress CHS in C57BL/6 mice (Fig 4b). This corresponded to
approximately half the UVA dose present in the MEdD of ssUVR.
It is unlikely that traces of UVB were responsible for this UVA-
induced systemic immunosuppression in C57BL/6 mice as the
percentage of contaminating UVB in the UVA spectrum was less
than 0.001%, thus delivering less than 0.0014 mJ per cm2 UVB.
Moreover, if this low dose of UVB was immunosuppressive, then
the Balb/c mice would also be expected to be immunosuppressed
by 1680 mJ per cm2 of UVA. Interestingly, as the dose of UVA was
increased, C57BL/6 mice recovered from immunosuppression
(Fig 4b). These two spectra were then combined to produce
ssUVR (Fig 4c). Because UVB and UVA were both able to
suppress primary immunity to oxazolone at low doses, ssUVR also
suppressed immunity at these doses. At higher doses, however,
although the UVB portion remained suppressive, the UVA
component was not, and therefore appeared to protect C57BL/6
mice from the immunosuppressive effects of UVB. Therefore the
dose±response for ssUVR was similar to that of UVA but different
to the dose±response for UVB in this mouse strain.
Balb/c mice showed positive control ear swelling responses of
27.4 6 1.4 with irritant controls of 5.9 6 1.0 3 10±2 mm. Balb/c
mice were also suppressed by low doses of UVB and displayed a
similar dose responsiveness to C57BL/6 mice (Fig 4a). In contrast
to C57BL/6 mice, however, Balb/c mice were unaffected by any
dose of UVA (Fig 4b). Because of this, when the two spectra were
combined to form ssUVR, UVA protection from the immuno-
suppressive effects of UVB was not observed; rather, higher doses
of ssUVR continued to be immunosuppressive (Fig 4c). Also,
because low dose UVA was unable to suppress the CHS response in
Balb/c mice (Fig 4b), the magnitude of ssUVR-induced suppres-
sion in Balb/c was less than in C57BL/6 mice (24% and 55%
suppression, respectively).
In experiments to test UVB susceptibility to systemic immuno-
suppression, Noonan and Hoffman (1994) showed that, compared
to Balb/c mice, C57BL/6 mice required much lower doses of
UVB to become systemically immunosuppressed, and the mice
were therefore classed as having a low and high UVB susceptibility,
respectively. This study used a UVB spectrum emitted from
un®ltered FS40 sunlamps having a peak at 313 nm and containing
mostly UVB (60%±65%) but also wavelengths below 290 nm. This
contrasts with our UVB spectrum mimicking the UVB portion of
the solar spectrum peaking at 320 nm, with essentially no
wavelengths in the UVC region (below 290 nm). Our study
showed no differences in susceptibility to UVB-induced systemic
immunosuppression between C57BL/6 and Balb/c mice, probably
because of the spectrum used. Therefore, previous reports of a
genetic susceptibility to UVB is probably dependent on the spectra
used and possibly the type of immune response being studied. An
earlier study by Noonan et al, however, showed that the dose±
response curves for UVB-induced local and systemic immunosup-
pression were the same, with Balb/c mice requiring 6.4 times more
UVB than C57BL/6 to attain identical systemic immunosuppres-
sion (Noonan and De Fabo, 1990). Therefore it is likely that
genetic susceptibility to UV is very dependent on spectrum and
dose, and our spectrum, which closely matched the UVB portion
of sunlight, did not differentiate between these strains.
C57BL/6 mice are prone to T helper 1 (Th1) immunity in
response to antigen (as measured by interferon-g), whereas Balb/c
mice are more likely to produce a Th2-type response [as measured
by interleukin-4 (IL-4) secretion] (Kelso et al, 1991). This genetic
predisposition to speci®c types of immune responses may partially
explain some of the contrasting results with the two strains
presented here. This is especially true considering that UV
irradiation can switch from a Th1- to a Th2-type immune
response (Simon et al, 1994; Garssen et al, 1999). Therefore,
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C57BL/6 may be more sensitive to UV-induced immunomodula-
tion of Th1 immunity than Balb/c mice.
It has not been previously examined whether there is a genetic
susceptibility to ssUVR or UVA, and, despite the lack of evidence
for a genetic susceptibility to UVB-induced immunosuppression in
this study, a difference was found between C57BL/6 and Balb/c
mice with regard to their susceptibility to both ssUVR and the
UVA portion of the solar spectrum. These results suggest that there
is a genetic dependence on the ability of UVA to modulate
immunity and that the mechanisms underlying UVA and UVB
immunosuppression may differ. Indeed, although we show here
that Balb/c mice are not suppressed by subedemal doses of UVA
and C57B/6 mice have a bell-shaped dose±response curve,
Nghiem et al (2001) have shown using a delayed type hypersen-
sitivity assay that C3H/HeN mice display a linear dose±response to
UVA-induced immunosuppression. These results indicate that the
possible reasons why previous studies have found UVA to be
immunosuppressive (Halliday et al, 1998; Nghiem et al, 2001) or
protective (Reeve et al, 1998) could be due to (i) the different doses
of UVA being used, (ii) the assay, or (iii) the genetics of the
irradiated host.
The mechanism of UVB-induced immune suppression is
thought to involve alterations to various cytokines, which lead to
systemic changes in immune cells. Alterations to IL-4, IL-10, IL-12
(Rivas and Ullrich, 1994), tumor necrosis factor (Vincek et al,
1993), and cis-urocanic acid (De Fabo and Noonan, 1983) levels are
all thought to be involved in this process. These changes affect
antigen presentation (Kripke and McClendon, 1986) and T cell
activation, including the generation of suppressor T cells in
UVB-exposed mice (Schmitt et al, 1995). Despite evidence that cis-
urocanic acid is produced following exposure to UVA, however
(El-Ghorr and Norval, 1999), the precise mechanism by which
UVA causes immunomodulation is unknown.
Few studies have explored the complex effects of ssUVR and its
component wavebands (UVA and UVB) on secondary immunity
where UV-exposed mice are re-sensitized to examine long-lived
regulatory cell activity. Suppression of primary immunity could be
the result of either lack of activation of effector cells or activation of
regulatory cells. To determine the difference between these events,
mice were re-sensitized with antigen without re-exposing to the
immunomodulating agent to determine whether activated regula-
tory cells modulate secondary immunity (see Fig 1). This protocol
has previously been used to demonstrate the activation of
regulatory cells when antigen is applied to carcinogen-treated
(Halliday et al, 1988) or UV-irradiated skin (Katiyar et al, 1999).
The role of UVB in inducing immune tolerance has been known
for some time, and is thought to be an important event in skin
tumor carcinogenesis as well as the observed lower immunization
rates following UVB exposure (Cooper et al, 1992).
In the secondary CHS, C57BL/6 mice showed positive control
ear swelling responses of 28.9 6 1.9 with irritant controls of
6.9 6 1.0 3 10±2 mm. This study has shown that C57BL/6 mice
became tolerant to oxazolone re-sensitization after exposure to low
doses (70 mJ per cm2) of UVB (Fig 5a). These mice displayed a
linear dose±response to UVB, because the level of immunological
tolerance increased with higher doses of UVB (up to 280 mJ per
cm2). This result is consistent with previous research into the effects
of UVB on tolerance (Shimizu and Streilein, 1994). The effect of
UVA on secondary immunity has received little research attention,
however. We found that C57BL/6 mice exposed to low dose UVA
(840 mJ per cm2) developed an enhanced response to oxazolone re-
sensitization (i.e., augmented memory). Whereas El-Ghorr and
Norval showed a nonsigni®cant enhancement of primary immunity
in C3H/HeN mice exposed to UVA from a Dr. Honle Light
Tower source (El-Ghorr and Norval, 1999), there have been no
previous reports of this UVA-induced memory enhancement
occurring in any system. In contrast, medium to higher doses of
UVA (from 1680 mJ per cm2 to 3360 mJ per cm2) had no effect on
secondary immunity (Fig 5b) showing that these doses of UVA did
not activate regulatory cells. This result is novel, and highlights the
Figure 5. UV Modulation of secondary immunity. The secondary
immune response was suppressed by UVB radiation in both Balb/c(h)
and C57BL/6 (j) mice in a linear dose-related manner (a). Low dose
UVA radiation enhanced the memory response in C57BL/6, whereas
higher UVA doses were required in Balb/c mice (b). Both C57BL/6 and
Balb/c mice became tolerant to oxazolone after exposure to low doses of
ssUVR, but recovered at higher doses (h). Eight to 10 wk after the
primary CHS experiment, the groups of C57BL/6 or Balb/c mice were
re-sensitized on their abdomen and CHS was assessed 7 d later by ear
challenge. The remainder of the legend is the same as for Fig 4.
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contrasting effects of UVA versus UVB as well as the different
effects of high dose versus low dose UVA. When the two spectra
were combined to form ssUVR, it was found that at low doses no
tolerance or memory enhancement was observed (Fig 5c). This is
probably due to the fact that, whereas UVB was tolerogenic, UVA
enhanced memory, and so the combination resulted in no
observable effect (Fig 6). As the dose of ssUVR increased,
however, C57BL/6 mice became tolerant to oxazolone
re-sensitization. This is probably because UVA no longer enhanced
memory at these doses, whereas UVB was tolerogenic. At the
maximum dose of ssUVR tested (3640 mJ per cm2), tolerance was
no longer observed. It is possible that the protective effects of UVA
during immune induction also protected mice from UVB-induced
tolerance, although the mechanism of this is not understood.
In the secondary CHS, Balb/c mice showed positive control ear
swelling responses of 37.2 6 1.3 with irritant controls of
4.4 6 1.3 3 10±2 mm. For Balb/c mice exposed to UVB
radiation, tolerance to oxazolone re-sensitization was also observed
in a linear dose-related manner, but compared to C57BL/6 mice
higher doses of UVB were required (210 mJ per cm2 compared to
70 mJ per cm2; Fig 5a). In contrast to C57BL/6 mice, low dose
UVA had no effect on secondary immunity in Balb/c mice. The
maximum dose of UVA (3360 mJ per cm2), however, also
enhanced memory (Fig 5b), although the magnitude of this
enhancement was less than that observed in C57BL/6 mice (9%
compared to 23%). When the two spectra were combined, low
dose ssUVR had no effect on tolerance, but Balb/c mice did
become tolerant to oxazolone re-sensitization at 2730 mJ per cm2,
re¯ecting the effect of UVB at its relevant dose. Also, in contrast to
the failure of Balb/c mice to recover from ssUVR-induced primary
immunosuppression, these mice were no longer tolerant to
oxazolone at higher doses of ssUVR (Fig 5c), probably because
the UVA component caused a slight enhancement of memory at
this dose. The mechanism of this UVA-induced memory enhance-
ment is not known. It is possible that this is a similar phenomenon
to high dose UVA protection from UVB-induced immunosup-
pression observed previously (Reeve et al, 1998) and in this study;
however, these events occurred at different doses.
These memory-enhancing effects of low dose UVA have wide
ranging implications for implementing immunization strategies.
Further research is required to determine whether low dose UVA
could be used to augment antitumor immunization strategies
leading to enhanced recall responses and long-term memory to
tumor-associated antigens. Furthermore, in contrast to UVB, no
dose of UVA caused immunologic tolerance in either mouse strain,
which also has important implications for host immune responses
against tumors. The caveat, however, is that, whereas low doses of
UVA enhanced memory, only slightly higher UVA doses were
immunosuppressive, and it would be dif®cult to deliver exactly the
right UVA dose to enhance memory without causing immuno-
suppression in an outbred population. It is still not known whether
primary or secondary immunosuppression contributes more to
carcinogenesis.
Because low dose UVA (840 mJ per cm2) caused memory
enhancement, medium dose UVA (1680 mJ per cm2) caused
immunosuppression, and high dose UVA (3360 mJ per cm2)
provided protection from immunosuppression, it is likely that
different doses of UVA switch on different events leading to the
complex dose±responses observed. Medium dose UVA as used by
El-Ghorr and Norval (10,000 mJ per cm2) may cause isomerization
of trans-urocanic acid to cis-urocanic acid (El-Ghorr and Norval,
1999), which in turn may lead to tumor necrosis factor and
immunosuppressive IL-10 or IL-4 being secreted (Rivas and
Ullrich, 1994), perhaps from keratinocytes, in®ltrating in¯amma-
tory macrophages and/or mast cells in the dermis. Another
possibility is that medium dose UVA suppresses immunity via a
nitric oxide or reactive oxygen dependent mechanism, which this
laboratory has previously shown using 6600 mJ per cm2 of UVA
(Halliday et al, 1999). In the absence of higher doses of UVA, this
event is suf®cient to cause immunosuppression. As the dose of
UVA is increased, however, this may turn on another mechanism,
such as the release of interferon-g and/or IL-12, which has been
previously described to occur in response to high dose UVA
(38,740 mJ per cm2) (Shen et al, 1999). This change in the cytokine
milieu may then counteract any immunosuppressive events caused
by lower UVA doses or any UVB present. The mechanism of low
dose UVA-induced memory enhancement is unknown, although it
is possible that this dose enables the activation or prolonged survival
of memory T cells and/or prevents regulatory CD4+ T cell
activation.
We found ssUVR to induce immunosuppression in a dose-
related manner between 455 and 3640 mJ per cm2 in Balb/c but
not C57BL/6 mice. This Balb/c response is similar to the linear
dose±response curves described for solar-simulated immunosup-
pression of C3H/HeN mice (Roberts and Beasley, 1995; Kim et al,
1998). In contrast to both these strains, C57BL/6 mice showed a
biphasic dose±response. It is possible that this bell-shaped curve
observed for ssUVR up to 3640 mJ per cm2 in C57BL/6 mice is
not universally observed in all mouse strains. Further dose±response
studies using spectra containing larger amounts of high wavelength
UVA over large dose ranges, however, are required to clarify this
issue.
In conclusion, dose±response studies have revealed new intrica-
cies in the effects of UV on immunomodulation (as summarized in
Fig 6). The UVA portion of sunlight was found to be
immunosuppressive at relatively low doses. This UVA dose was
less than that contained in doses of ssUVR, which caused barely
detectable sunburn. Furthermore, this UVA-induced immunosup-
pression only occurred in one of the two mouse strains studied,
implying a genetic susceptibility to UVA-induced immunosuppres-
sion. This result has important implications for the use of solariums
by humans, which claim to use ``harmless'' UVA for cosmetic
tanning purposes. If certain sections of the community are found to
be susceptible to UVA-induced immunosuppression, then solarium
use and sunbaking in general could greatly enhance the develop-
ment of skin cancer in these individuals. These results also reinforce
the need for broad-spectrum sunscreen use by the community. At
higher UVA doses, mice were no longer immunosuppressed, but
rather were protected from solar-simulated immunosuppression,
although this protection only occurred in one of the two mouse
strains studied, which again suggests a genetic component to UV
immunomodulation. Both these results show that UVA may have
different immunologic functions at different doses and further
highlights the importance of detailed UVA dose±response studies of
UV-induced immunosuppression and carcinogenesis. This point is
further reinforced by the discovery that even lower UVA doses
enhanced secondary immunity, whereas higher UVA doses had no
observable effect. At no stage in either mouse strain did UVA
induce tolerance. These results imply that UVA may provide
Figure 6. Summary of the complex immunomodulating effects
of UVB, UVA, and ssUVR on C57BL/6 mice.
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memory enhancement to augment vaccination therapies.
Considering that this effect of low dose UVA was only observed
in one out of two mouse strains, however, it is unclear whether this
would be effective in a large percentage of humans.
These studies have examined the effects of UVB and UVA
on CHS as a model of systemic immunosuppression. Different
results may have been obtained with an alternative immunologic
endpoint such as delayed-type hypersensitivity. Because of the
complex and long-term nature of carcinogenesis, the immune
response to a developing tumor antigen is unlikely to be
accurately mirrored by CHS. Nevertheless, such studies enable
some hypotheses to be drawn regarding the relative roles of
different doses and wavebands on UV suppression of antitumor
immunity. In contrast to UVA, UVB caused both primary
immunosuppression and tolerance at low doses, suggesting that
UVB is a potent immunosuppressive agent, which could have
profound in¯uences on carcinogenesis and long-term memory.
The dose and regime of sunlight exposure that causes cancer in
humans is unknown. There is some evidence that the rate of
UV exposure required for the development of melanoma and
nonmelanoma skin cancer in humans differs (Armstrong and
Kricker, 1993; Kricker et al, 1995). As ssUVR caused
immunosuppression over a narrow dose range, it is possible
that skin cancer induction would also be more prevalent at
these moderate doses, at least for some skin cancer types in
some individuals. These complex interactions between UV
wavebands are therefore likely to be important for both the
induction of and long-term protection against human skin
cancer.
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